Lumos

 Lumos Diagnostics Secures $15M in Series A Funding from Planet Innovation

Retrieved on: 
Wednesday, February 5, 2020

Lumos Diagnostics announced the closing of U.S. $15 million in Series A funding from Planet Innovation , an Australia-based healthtech innovation and commercialization company.

Key Points: 
  • Lumos Diagnostics announced the closing of U.S. $15 million in Series A funding from Planet Innovation , an Australia-based healthtech innovation and commercialization company.
  • Lumos Diagnostics, a spinout from Planet Innovation, merged with RPS Diagnostics in May 2019, creating a diverse healthcare company that combines the FebriDx test and commercial experience with a novel and proprietary digital reader platform.
  • Sam Lanyon, chairman of the board for Lumos Diagnostics and co-chief executive officer for Planet Innovation states, Planet Innovation is focused on breakthrough technology and making investments that will have a global impact on healthcare.
  • It is obvious that Lumos Diagnostics is poised for rapid growth and Planet Innovation is keen to support and accelerate the process.

Ubersmith CEO to Deliver Keynote at NamesCon Global

Retrieved on: 
Tuesday, January 21, 2020

NEW YORK, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Kurt Daniel, CEO of Ubersmith, a global leader in subscription business management software, will deliver a keynote address at NamesCon Global , the largest website domain industry event with an expected 1,300 attendees from around the world.

Key Points: 
  • NEW YORK, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Kurt Daniel, CEO of Ubersmith, a global leader in subscription business management software, will deliver a keynote address at NamesCon Global , the largest website domain industry event with an expected 1,300 attendees from around the world.
  • A perennial highlight of the NamesCon Global event is the auction.
  • Headquartered in New York, Ubersmith provides billing, infrastructure and ticketing solutions that are open, scalable and integrated.
  • Ubersmith customers include Codero, DataBank, Endurance International Group, GMO, Lumos, Namecheap, NS1, Sitey, T5, and WOW.For more, please visit https://ubersmith.com .

NewLink Genetics Responds to Proposal from Evercel

Retrieved on: 
Monday, December 16, 2019

AMES, Iowa, Dec. 16, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) (NewLink or the Company) today publicly announced its rejection of the unsolicited acquisition proposal received on November 5, 2019 from Evercel, Inc. (Evercel) (OTC:EVRC), a holding company with a primary operating business selling line matrix printers and accessories.

Key Points: 
  • AMES, Iowa, Dec. 16, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) (NewLink or the Company) today publicly announced its rejection of the unsolicited acquisition proposal received on November 5, 2019 from Evercel, Inc. (Evercel) (OTC:EVRC), a holding company with a primary operating business selling line matrix printers and accessories.
  • The NewLink Board of Directors (the Board), consistent with its fiduciary duties and in consultation with outside financial and legal advisors, thoroughly evaluated the Evercel proposal and has determined that it is not in the best interests of NewLinks stockholders.
  • As a result, the Evercel proposal does not satisfy the requirements in the Lumos Merger Agreement for granting due diligence access or commencing negotiations with respect to a competing proposal.
  • Immediately following the closing of the merger, Lumos will become a wholly-owned subsidiary of NewLink, and NewLink will be renamed Lumos Pharma, Inc. and is expected to trade on Nasdaq under the symbol LUMO.

NewLink Genetics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Retrieved on: 
Wednesday, November 6, 2019

AMES, Iowa, Nov. 06, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced financial results for the third quarter ended September 30, 2019 and provided an update on corporate activities.

Key Points: 
  • AMES, Iowa, Nov. 06, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced financial results for the third quarter ended September 30, 2019 and provided an update on corporate activities.
  • On September 30, 2019, NewLink announced its intent to merge with Lumos Pharma, a private clinical-stage biopharmaceutical company targeting rare and neglected diseases.
  • NewLink will file a proxy statement with the Securities and Exchange Commission (SEC) providing additional information about the proposed merger.
  • Cash Position: NewLink Genetics ended the quarter on September 30, 2019, with cash and cash equivalents totaling $98.5 million compared to $120.7 million December 31, 2018.

NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases

Retrieved on: 
Monday, September 30, 2019

Under the terms of the agreement, NewLink will issue Lumos Pharma stockholders NewLink common stock in exchange for their shares in Lumos such that Lumos Pharma stockholders will own approximately 50% of NewLink.

Key Points: 
  • Under the terms of the agreement, NewLink will issue Lumos Pharma stockholders NewLink common stock in exchange for their shares in Lumos such that Lumos Pharma stockholders will own approximately 50% of NewLink.
  • Our board and entire team are pleased to announce this exciting merger with NewLink, said Rick Hawkins, CEO of Lumos Pharma.
  • Working toward the development and commercialization of novel therapies for rare diseases remains the cornerstone of Lumos Pharmas strategy.
  • Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare and neglected diseases.

INAP Names Michael T. Sicoli President and CFO

Retrieved on: 
Tuesday, August 27, 2019

Its a great opportunity to once again team up with Mike to take INAP to the next level in 2020, said Mr. Aquino, Chief Executive Officer.

Key Points: 
  • Its a great opportunity to once again team up with Mike to take INAP to the next level in 2020, said Mr. Aquino, Chief Executive Officer.
  • Mr. Sicoli recently served as a director of Lumos Networks, a fiber-based bandwidth infrastructure and service provider in the Mid-Atlantic region.
  • INAP operates in 21 metropolitan markets, primarily in North America, with data centers connected by a low-latency, high-capacity fiber network.
  • INAP has over one million gross square feet in its portfolio, with approximately 600,000 square feet of sellable data center space.

Lumos Networks Receives ‘Build Your Best Network’ Award at ADTRAN Broadband and Business Solutions Summit

Retrieved on: 
Wednesday, August 14, 2019

ADTRAN, Inc. , (NASDAQ:ADTN), a leading provider of next-generation open networking and subscriber experience solutions, today announced Lumos Networks was presented the ADTRAN Build Your Best Network Award at the Broadband and Business Solutions Summit.

Key Points: 
  • ADTRAN, Inc. , (NASDAQ:ADTN), a leading provider of next-generation open networking and subscriber experience solutions, today announced Lumos Networks was presented the ADTRAN Build Your Best Network Award at the Broadband and Business Solutions Summit.
  • Network operators like Lumos Networks are on the forefront of network innovation and service creation, ADTRAN Vice President of Sales for Americas and Head of Global Business Development Craig Stein said.
  • This award recognizes the results, and the vision, that Lumos Networks has displayed in terms of service delivery, network impact and commitment to innovation.
  • We are honored to be recognized with the Build Your Best Network Award, Lumos Networks Senior VP and General Manager Diego Anderson said.

Lumos Diagnostics and RPS Diagnostics Merge to Create Full Service Development Company and Support International Commercialization of FebriDx

Retrieved on: 
Wednesday, May 29, 2019

Lumos Diagnostics , a California-based full-service point-of-care (POC) diagnostic development company and previous spinoff from Australia-based Planet Innovation and RPS Diagnostics , a Florida-based commercial diagnostic developer, manufacturer, and marketer of POC diagnostic tests, announced today that they have merged.

Key Points: 
  • Lumos Diagnostics , a California-based full-service point-of-care (POC) diagnostic development company and previous spinoff from Australia-based Planet Innovation and RPS Diagnostics , a Florida-based commercial diagnostic developer, manufacturer, and marketer of POC diagnostic tests, announced today that they have merged.
  • The combined company will be called Lumos Diagnostics.
  • Lumos provides assay development and manufacturing services for customized POC tests as well as directly develops, manufactures, and will commercialize a suite of Lumos-branded POC tests.
  • For more information on Lumos Diagnostics, visit lumosdiagnostics.com , and for more information on FebriDx, visit febridx.com .

SXSW Release It 2019 Pitch Competition Announces Lumos Helmet as Winner

Retrieved on: 
Saturday, March 9, 2019

AUSTIN, Texas, March 9, 2019 /PRNewswire/ -- The newest product from Lumos Helmet called the Lumos "Matrix" Helmet, has been announced as the winner of SXSW's (South by Southwest) Release It Pitch Competition and will receive the award at the SXSW Interactive Innovation Awards on March 11.

Key Points: 
  • AUSTIN, Texas, March 9, 2019 /PRNewswire/ -- The newest product from Lumos Helmet called the Lumos "Matrix" Helmet, has been announced as the winner of SXSW's (South by Southwest) Release It Pitch Competition and will receive the award at the SXSW Interactive Innovation Awards on March 11.
  • SXSW Release It provides a platform for companies to launch a new and innovative product or service during a pitch competition on the opening day of the SXSW Conference.
  • The Lumos "Matrix" Helmet is the latest and newest helmet from Lumos.
  • Targeted at urban city cyclists, skaters, and electric scooter riders, the Lumos "Matrix" Helmet is designed with a sleek, urban aesthetic.

Alaska Communications Appoints Peter D. Aquino to Its Board of Directors

Retrieved on: 
Wednesday, February 20, 2019

Alaska Communications Systems Group, Inc. (NASDAQ: ALSK), the leading provider of advanced broadband and managed IT services for businesses and consumers in Alaska, will appoint Peter D. Aquino, an industry veteran, to the board effective March 18, 2019.

Key Points: 
  • Alaska Communications Systems Group, Inc. (NASDAQ: ALSK), the leading provider of advanced broadband and managed IT services for businesses and consumers in Alaska, will appoint Peter D. Aquino, an industry veteran, to the board effective March 18, 2019.
  • An independent director, Mr. Aquino will expand the board to nine members.
  • We would like to thank Aegis Financial, our largest shareholder, for the introduction, said Ned Hayes, Alaska Communications Chairman of the Board.
  • Mr. Aquino recently served on the board of directors of Lumos Networks (Nasdaq: LMOS) and FairPoint Communications, Inc. (Nasdaq: FRP), prior to both being sold in 2017.